A survey of senior biotech executives in New Jersey reflected continued growth in the state's life sciences industry in the past three years despite major companies' downsizing and consolidation efforts. The number of biotech workers increased 50% since 2007, and the majority of executives said they expect further expansion driven by state programs, according to the study, which was conducted by BioNJ and Ernst & Young.

Related Summaries